{"filing":{"accession_number":"0001493152-26-044309","cik":"0000109657","ticker":"GTBP","company_name":"GT Biopharma, Inc.","form":"8-K","filing_date":"2026-09-25","report_date":"2026-09-22","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315226044309/form8-k.htm"},"events":[{"id":35110,"run_id":32332,"accession_number":"0001493152-26-044309","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"GT Biopharma received a Nasdaq delisting notice on November 20, 2025 for failing to maintain the $1.00 minimum bid price requirement, was granted a 180-day compliance period until November 16, 2026, and on September 22, 2026 notified investors that it has regained compliance by maintaining a closing bid price above $1.00 per share for at least ten consecutive business days. This disclosure directly addresses the resolution of a material delisting risk under Item 8.01 (Other Events).","company_name":"GT Biopharma, Inc.","ticker":"GTBP","filing_date":"2026-09-25","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":39049,"accession_number":"0001493152-26-044309","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"GT Biopharma received a Nasdaq delisting notice on November 20, 2025 for failing to maintain the $1.00 minimum bid price requirement, was granted a 180-day compliance period until November 16, 2026, and on September 22, 2026 notified investors that it has regained compliance by maintaining a closing bid price above $1.00 per share for at least ten consecutive business days. This disclosure directly addresses the resolution of a material delisting risk under Item 8.01 (Other Events).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T20:15:29.962715+00:00","company_name":"GT Biopharma, Inc.","ticker":"GTBP","filing_date":"2026-09-25"}]}